PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-0.33
↑ 98% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
-20.57
Historical baseline
PeriodValueYoY Change
2025-0.33+36.2%
2024-0.52+71.8%
2023-1.84+55.8%
2022-4.16+73.3%
2021-15.59+77.8%
2020-70.14-13.7%
2019-61.69-501.3%
2018-10.26-